Funding news
Xaira Therapeutics logo

Xaira Therapeutics Raises $550.

Recently funded · $550.0M Series bHospitals and Health CareUSView source

Get the full Xaira Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The intersection of artificial intelligence and biotechnology just saw a major capital infusion, as San Francisco Bay Area-based Xaira Therapeutics announced it has raised $550.0M in a Series B funding round. The integrated company is building an ambitious platform to learn the "language of life," aiming to transform how diseases are treated by rethinking the entire drug discovery and development process.

Xaira brings together leading talent across machine learning research, expansive data generation, and robust therapeutic product development to achieve its goals.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Emesent logo

Emesent

Australia

$167.0M
2
stenon logo

stenon

Germany

$19.4M
3
Ollama logo

Ollama

United States

$65.0M
4
Databento logo

Databento

United States

$97.0M
5
Kraken Technology Group logo

Kraken Technology Group

United Kingdom

$173.7M